StockData
ADMA Biologics, Inc. logo

ADMA Biologics, Inc. (ADMA) stock

ADMANasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 17/3028% below fair value
$13.56−0.07 (-0.51%)

Close on Nov 18, 2026Market cap $3.04BP/E 19.4Yield –

ADMA Biologics pe ratio

The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.

ADMA Biologics's pe ratio was 18.8× on Nov 11, 2026, against 22.6× a year earlier. Over the last 2 years it ranged from 11.7× to 142.8×, with a median of 21.5×.

PE Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 202618.8×−2.6
2025Dec 31, 202521.5×−39.8
2024Dec 31, 202461.3×–

More ADMA Biologics figures

See a number that looks wrong?